Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar-Apr;67(2):206.
doi: 10.4103/ijd.ijd_482_21.

Apremilast in Paediatric Dermatoses - A Comprehensive Review

Nibedita Patro  1 , Maitreyee Panda  2 , Mrityunjay Dash  3 , Anupam Das  4
Affiliations
Review

Apremilast in Paediatric Dermatoses - A Comprehensive Review

Nibedita Patro et al. Indian J Dermatol. 2022 Mar-Apr.

Abstract

Apremilast has recently garnered attention in the management of multiple dermatological conditions including psoriasis. The comparable effectiveness with immunosuppressive drugs and a favorable side effect profile makes the drug, a prudent alternative for managing a gamut of dermatoses. In this article, we have reviewed the literature on apremilast use in children.

Keywords: Apremilast; dermatology; pediatric population.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Smith RL. Paediatric psoriasis treated with apremilast. JAAD Case Rep. 2016;2:89–91. - PMC - PubMed
    1. Saporito RC, Cohen DJ. Apremilast use for moderate to severe atopic dermatitis in pediatric patients. Case Rep Dermatol. 2016;8:179–84. - PMC - PubMed
    1. Chhabra G, Verma P. Steroid-resistant alopecia totalis in a child successfully treated with oral apremilast and platelet-rich plasma therapy. Dermatol Ther. 2019;32:e13082. doi: 10.1111/dth.13082. - PubMed
    1. Hassanandani T, Panda M, Patro N, Kar D. Colocalization of psoriasis and vitiligo treated with apremilast and narrowband ultraviolet B combination in an adolescent girl. Indian J Paediatr Dermatol. 2020;21:70–2.
    1. Otezla (apremilast) Prescribing Information. Summit, New Jersey: Celgene Corp; 2014.